Certara's Presence in Investor Conferences
Certara, Inc. (NASDAQ: CERT), a prominent name in the field of drug development, is gearing up for a series of important investor conferences that emphasize its leadership and innovative contributions to model-informed drug development.
Upcoming Conference Schedule
During these conferences, the management of Certara will provide insights into their strategies and advancements in biopharmaceuticals. The schedule is as follows:
UBS Global Healthcare Conference
This event is set for a Tuesday in November at 2:00 PM ET. Attendees can expect a detailed discussion on Certara's innovative approaches to accelerating medicine development.
Jefferies Global Healthcare Conference in London
Later in November, Certara will participate in the Jefferies Global Healthcare Conference. This is another opportunity to highlight how their efforts are transforming the pharmaceutical landscape.
Stephens Annual Investment Conference
On the same day as the Jefferies Conference, Certara will also be attending the Stephens Annual Investment Conference, offering investors a comprehensive insight into their operations.
Accessing the Webcasts
For those interested in staying informed, live webcasts of the conferences will be available on Certara's investor relations website. These sessions will also be accessible for replay for a duration following the events, ensuring everyone gets a chance to capture important insights.
About Certara
Certara accelerates medicines by utilizing advanced biosimulation software, technology, and service frameworks that transform the traditional processes of drug discovery and development. With a clientele that includes over 2,400 biopharmaceutical companies and regulatory agencies across more than 70 countries, Certara solidifies its role as a global leader in the biopharma industry.
Investor Relations and Contact Information
For further inquiries, individuals can reach out to David Deuchler at Gilmartin Group via email. As an established figure in investor relations, he can provide additional details about Certara's initiatives and future developments.
Frequently Asked Questions
What is Certara's main focus in drug development?
Certara primarily focuses on utilizing biosimulation software and technology to enhance drug discovery and development processes.
When will the investor conferences take place?
The UBS Global Healthcare Conference will occur on a Tuesday in November, followed by the Jefferies Global Healthcare Conference on the same day, and the Stephens Annual Investment Conference.
Where can I find the live webcasts for the conferences?
Live webcasts will be available on Certara's investor relations website and can be replayed afterward for those who cannot attend live.
How many countries does Certara operate in?
Certara operates in over 70 countries, providing services to many biopharmaceutical companies and regulatory bodies worldwide.
Who should I contact for more information about Certara?
For additional inquiries, contact David Deuchler at Gilmartin Group. His expertise is invaluable for addressing investor questions.
